IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin… - Microbiology …, 2022 - Am Soc Microbiol
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
IFIT3 is increased in serum from patients with chronic hepatitis B virus (HBV) infection and promotes the anti-HBV effect of interferon alpha via JAK-STAT2 in vitro.
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin, W Wu, T Chen… - 2022 - cabidigitallibrary.org
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro.
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin, W Wu… - Microbiology …, 2022 - europepmc.org
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
[HTML][HTML] IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 …
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin, W Wu… - Microbiology …, 2022 - ncbi.nlm.nih.gov
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin… - Microbiology …, 2022 - pubmed.ncbi.nlm.nih.gov
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin, W Wu, T Chen… - 2022 - agris.fao.org
Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
[引用][C] IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In …
S Xu, J Huang, Z Xun, S Li, Y Fu, N Lin, W Wu, T Chen… - 2022 - europepmc.org
Increasing evidence indicates that interferon alpha (IFN-a) therapy is an effective treatment
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …
option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been …